Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular oxidative stress pathways in vascular smooth muscle cells (VSMCs) represent a complex network of biochemical processes that regulate the balance between reactive oxygen species (ROS) production and antioxidant defense mechanisms [1]. In VSMCs, ROS are primarily generated by enzymes such as NADPH oxidases (NOX1, NOX4), mitochondria, and xanthine oxidase in response to stimuli like angiotensin II, growth factors, and mechanical strain [2]. While physiological levels of ROS act as critical secondary messengers in signal transduction, an imbalance leading to oxidative stress promotes VSMC hypertrophy, migration, and phenotypic switching [3]. These cellular changes are fundamental drivers of vascular pathologies, including hypertension, atherosclerosis, and restenosis after angioplasty [4]. Therapeutic strategies often focus on specific components of these pathways, such as inhibiting NOX enzymes or activating the Nrf2-mediated antioxidant response, to mitigate oxidative damage and restore vascular function [5]. However, the complexity and redundancy of these pathways, along with the dual role of ROS in both health and disease, present significant challenges for therapeutic development [1].
Modulation of reactive oxygen species (ROS) production through inhibition of enzymes like NADPH oxidase or enhancement of antioxidant defenses via Nrf2 activation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular oxidative stress pathways in vascular smooth muscle cells.